Tag: Human Papillomavirus (HPV)
Low Incidence of Cervical Cancer, CIN3+ for HPV-Negative Women
Low incidence may support extension of cervical screening interval beyond five years
Denver Clinic Boosts HPV Vaccination Rates
Increased rates by bundling vaccines, offering vaccines at every visit, standard orders
More Evidence HPV Vaccine Protects Against Cervical Cancer
Protection appears to occur even when only one or two of the recommended doses are given
Opt-Out Provisions Up Parent Support for HPV Requirement
Race/ethnicity, attitudes about HPV vaccine linked to odds of agreeing with school-entry HPV requirements
ACS Endorses CDC’s HPV Vaccine Guidelines
Boys and girls should start series at age 11 or 12 to protect against human papillomavirus
Approval of First HPV Test for Use With SurePath Preservative Fluid
For cervical cells obtained for Pap test, collected in SurePath Preservative Fluid
ASCO Presents Guidelines for Increasing HPV Vaccine Uptake
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
HIV-Seropositive CIN3+ Patients Have Lower HPV16 Prevalence
HIV-seropositive women have lower HPV-16, higher non-alpha-9 oncHPV prevalence
Most HPV+ OPSCC Recurrence, Toxicity Events Occur Early
Two-thirds of disease recurrence and late toxicity events occur within six months
ACIP Approves 2016 Adult Immunization Schedule
Changes to schedule for HPV, pneumococcal, and meningococcal vaccines
